LeadNearLeadNear
Akebia Therapeutics logo
Verified

Akebia Therapeutics

Drug Manufacturing & Research

Founded: 2007
Headquarters: 245 First Street, Cambridge, Massachusetts 02142, USA
Overview
Location
Massachusetts, United States
Headquarter
245 First Street, Cambridge, Massachusetts 02142, USA
No of Employees
400
Industry
Drug Manufacturing & Research
Company Type
Public Company
Founded
2007
CEO
John P. Butler
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
318 Million USD
Total Funding
$155M
Recent Funding Amount
$55M
No of Funding Rounds
2
Founders
Joseph Cook
Social Handles

Company overview

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries,

Employees by Level

C-Level

7

VP-Level

22

Director

109

Manager

76

Non-Manager

157

Top Contacts

237

Available Jobs at Akebia Therapeutics

Top C-suite Members of Company

Connect with key decision-makers at Akebia Therapeutics. View the C-suite executives and leadership team.

NameTitleContactAction
Erik OstrowskiSenior VP, Chief Financial Officer & Chief Bue****i@akebia.comShow details
Nikki HadasChief Legal Officern****s@akebia.comShow details
Steven BurkeSenior VP, Research Development & Chief Medics****e@akebia.comShow details
Richard MalabreChief Accounting Officerr****e@akebia.comShow details
Elizabeth RodriguezAssistant Corporate Controllere****z@akebia.comShow details
Kristie BolieauVice President, Corporate Controllerk****u@akebia.comShow details
Elizabeth BonillaAssistant Corporate Controllere****a@akebia.comShow details
Ron FriesonMember Board of Directorsr****n@akebia.comShow details
Geoffrey RossSenior VP, Drug Safety, Pv & Medical Affairsg****s@akebia.comShow details
Amanda FooteDevelopment Operations & External Collaboratia****e@akebia.comShow details
Tracey VetterickVice President, Portfolio Strategy & Corporatt****k@akebia.comShow details
Steven BurkeSenior VP, Research Development & Chief Medics****e@akebia.comShow details
Christopher SilvaProcurement & Sourcing Vice President, Supplyc****a@akebia.comShow details

Employees Contact

Connect with company employees using the separately sourced, masked contact dataset.

Loading employee contact information…

Email formats

Discover the professional email patterns used at Akebia Therapeutics.

Email formatExamplePercentage
Email formats for Akebia Therapeutics are not available.

Email verification tool

Find and verify professional email addresses for Akebia Therapeutics.

Technology stack

RSS
Miscellaneous

Akebia Therapeutics uses RSS to enhance their digital capabilities and improve operational efficiency.

Open Graph
Miscellaneous

Akebia Therapeutics uses Open Graph to enhance their digital capabilities and improve operational efficiency.

HTTP/3
Miscellaneous

Akebia Therapeutics uses HTTP/3 to enhance their digital capabilities and improve operational efficiency.

Google Analytics
Analytics

Akebia Therapeutics uses Google Analytics to measure website traffic and user engagement, generating actionable insights for optimizing online performance and marketing campaigns.

reCAPTCHA
Security

Akebia Therapeutics uses reCAPTCHA to differentiate human users from automated bots, protecting websites and online services from spam, abuse, and fraudulent activity while maintaining a seamless user experience.

Google Font API
Font scripts

Akebia Therapeutics uses Google Font API to easily embed a diverse range of high-quality fonts on its website, enhancing typography, branding, and user experience with robust performance.

Cloudflare
CDN

Akebia Therapeutics uses Cloudflare to enhance the performance, security, and reliability of its web applications by leveraging a global network for content delivery, DDoS protection, and WAF services.

DoubleClick Floodlight
Advertising

Akebia Therapeutics uses DoubleClick Floodlight to enhance their digital capabilities and improve operational efficiency.

Google Tag Manager
Tag managers

Akebia Therapeutics uses Google Tag Manager to efficiently deploy and manage website tracking tags, marketing pixels, and analytics scripts without direct code modifications, centralizing data collection and accelerating marketing and analytics initiatives.

jQuery UI
JavaScript libraries

Akebia Therapeutics uses jQuery UI to enhance web applications with a robust set of ready-to-use, customizable UI widgets and interactions, simplifying development and improving user experience.

jQuery Migrate
JavaScript libraries

Akebia Therapeutics uses jQuery Migrate to ensure backward compatibility and smooth upgrades to newer jQuery versions by restoring deprecated features and behaviors, preventing existing scripts from breaking and aiding in code modernization.

jQuery
JavaScript libraries

Akebia Therapeutics uses jQuery to simplify client-side scripting, enabling faster and more efficient manipulation of the HTML DOM, event handling, animation, and AJAX interactions across various web browsers.

WP Engine
Hosting

Akebia Therapeutics uses WP Engine to power its WordPress websites with a high-performance, secure, and scalable managed hosting platform, leveraging developer tools and expert support for optimal site management and growth.

Priority Hints
Performance

Akebia Therapeutics uses Priority Hints to enhance their digital capabilities and improve operational efficiency.

Yoast SEO Premium
SEO

Akebia Therapeutics uses Yoast SEO Premium to enhance their digital capabilities and improve operational efficiency.

Yoast SEO
SEO

Akebia Therapeutics uses Yoast SEO to optimize website content for search engines by providing real-time analysis and actionable recommendations, thereby improving search engine rankings and organic traffic.

MediaElement.js
Video players

Akebia Therapeutics uses MediaElement.js to enhance their digital capabilities and improve operational efficiency.

PHP
Programming languages

Akebia Therapeutics uses PHP to develop dynamic, data-driven web applications and websites, leveraging its robust server-side scripting capabilities for powerful and scalable online experiences.

MySQL
Databases

Akebia Therapeutics uses MySQL to store, manage, and retrieve structured data efficiently and reliably, powering scalable web applications and critical business operations with robust data management capabilities.

WordPress
CMS

Akebia Therapeutics uses WordPress to enhance their digital capabilities and improve operational efficiency.

Frequently Asked Questions

What is the address of Akebia Therapeutics's headquarters?

Akebia Therapeutics is headquartered at 245 First Street, Cambridge, Massachusetts 02142, USA.

How can I contact Akebia Therapeutics by phone?

You can reach Akebia Therapeutics by calling their customer support number at 617-871-2097.

Which stock symbol does Akebia Therapeutics trade under?

The stock ticker for Akebia Therapeutics is AKBA.

What is the official website for Akebia Therapeutics?

You can visit Akebia Therapeutics's official website at www.akebia.com.

How much revenue does Akebia Therapeutics generate?

Akebia Therapeutics reports an annual revenue of approximately 318 Million USD.

What is the SIC code for Akebia Therapeutics?

The Standard Industrial Classification (SIC) code for Akebia Therapeutics is 87,873.

What is the NAICS code for Akebia Therapeutics?

Akebia Therapeutics falls under the NAICS code 54,541.

How many people work at Akebia Therapeutics?

Akebia Therapeutics has a workforce of about 400 employees.

Which technologies are used by Akebia Therapeutics?

Akebia Therapeutics utilizes technologies like RSS, Open Graph, HTTP/3.

Who is the Chief Executive Officer (CEO) of Akebia Therapeutics?

The CEO of Akebia Therapeutics is John P. Butler.

How can I get in touch with Akebia Therapeutics?

To contact Akebia Therapeutics, call 617-871-2097 or visit their website at www.akebia.com

Is Akebia Therapeutics a publicly traded company?

Yes, Akebia Therapeutics is publicly listed and trades under the stock symbol AKBA.

How much total funding has Akebia Therapeutics secured so far?

To date, Akebia Therapeutics has raised $155M across 2 funding round(s).

Which industry is Akebia Therapeutics part of?

Akebia Therapeutics operates in the Drug Manufacturing & Research, Pharmaceuticals, Healthcare industry.

Who are the main competitors of Akebia Therapeutics?

Key competitors of Akebia Therapeutics include NGM Bio, Lexicon Pharmaceuticals, Puma Biotechnology, Synergy Pharmaceuticals

Which companies has Akebia Therapeutics acquired?

Acquisitions by Akebia Therapeutics include Keryx Biopharmaceuticals .

Who holds the CFO position at Akebia Therapeutics?

Erik Ostrowski serves as the Chief Financial Officer (CFO) at Akebia Therapeutics.

Where can I find Akebia Therapeutics on social media?

You can follow Akebia Therapeutics on Linkedin, Twitter, Facebook to stay updated with their latest news and services.

When did Akebia Therapeutics complete its most recent funding round?

Akebia Therapeutics latest funding round closed on Jan 30, 2024 with the amount of $55 Million